Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Navigating Chinese Health Care Reform: Opportunities And Pitfalls

This article was originally published in The Gray Sheet

Executive Summary

Health care reform in China will infuse a significant amount of money into Chinese health services, some of which will trickle down to support new technologies, but medical device manufacturers should proceed with caution, experts advise

You may also be interested in...



Opportunities Ripe For Device Firms In Emerging-Market Heartlands

Device and diagnostics companies can find new growth opportunities by marketing their wares in developing countries' smaller cities and towns, not just big ones, experts said Sept. 30 at a Wells Fargo Securities Emerging Markets Forum in New York

Opportunities Ripe For Device Firms In Emerging-Market Heartlands

Device and diagnostics companies can find new growth opportunities by marketing their wares in developing countries' smaller cities and towns, not just big ones, experts said Sept. 30 at a Wells Fargo Securities Emerging Markets Forum in New York

Opportunities Ripe For Device Firms In Emerging-Market Heartlands

Device and diagnostics companies can find new growth opportunities by marketing their wares in developing countries' smaller cities and towns, not just big ones, experts said Sept. 30 at a Wells Fargo Securities Emerging Markets Forum in New York

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT028086

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel